Context: T 3 action in neurons is essential for brain development. Recent evidence indicates that monocarboxylate transporter 8 (MCT8) is important for neuronal T 3 uptake. Hemizygous mutations have been identified in the X-linked MCT8 gene in boys with severe psychomotor retardation and elevated serum T 3 levels.
Results:
The mutations identified in MCT8 comprise four deletions (24.5 kb, 2.4 kb, 14 bp, and 3 bp), three missense mutations (Ala224Val, Arg271His, and Leu471Pro), a nonsense mutation (Arg245stop), and a splice site mutation (94 amino acid deletion). All tested mutants were inactive in uptake and metabolism assays, except MCT8 Arg271His, which showed approximately 20% activity vs. wild-type MCT8.
Conclusion:
These findings support the hypothesis that the severe psychomotor retardation and elevated serum T 3 levels in these patients are caused by inactivation of the MCT8 transporter, preventing action and metabolism of T 3 T HYROID HORMONE IS essential for the development of the brain (1, 2) . The bioavailability of T 3 in the brain is locally regulated through the interplay of two types of cells, astrocytes and neurons. Astrocytes express the type II deiodinase that converts the prohormone T 4 to T 3 , which is subsequently transported to the neurons, the major target cells for thyroid hormone in the brain (3, 4) . In addition to nuclear T 3 receptors, neurons express the type III deiodinase (D3), which catalyzes termination of T 3 activity. Multiple transporters are involved in cellular iodothyronine uptake and efflux in different tissues (5, 6) . Recent evidence suggests that monocarboxylate transporter 8 (MCT8) is important for T 3 uptake into central neurons (7, 8) .
The MCT8 gene is located on chromosome Xq13.2; depending on which of the two possible translation start sites is used, it codes for a protein of 613 or 539 amino acids, containing 12 putative transmembrane domains (TMDs). MCT8 is expressed in numerous human tissues, including brain, heart, placenta, lung, kidney, skeletal muscle, and liver. We and others have reported on patients with mutations in the MCT8 gene (9 -13) . These patients, all male, show a distinct phenotype of severe psychomotor retardation in combination with elevated serum levels of T 3 .
In the present study, we provide functional characteristics of six MCT8 mutations. The functional consequences of mutations in MCT8 on cellular uptake and metabolism of T 3 were determined in JEG3 cells transfected with wild-type or mutant MCT8 alone or in cells cotransfected with MCT8 and D3.
Patients and Methods

Serum and DNA analyses
Approval for these studies was obtained from the medical ethical committee of the Erasmus Medical Center. Informed consent was obtained from the parents of all patients. Serum T 4 , free T 4 , T 3 , and TSH were measured by Vitros ECI technology (Immunodiagnostic System; Ortho-Clinical Diagnostics, Beerse, Belgium). The coding sequence of MCT8 was analyzed in patient DNA using intronic primers flanking the six exons.
Cloning and site-directed mutagenesis of human MCT8
Construction of a human MCT8 cDNA-containing pcDNA3 expression vector was described previously (14) . The point mutations identified in patients (Table 1) were introduced in MCT8 cDNA using the QuickChange Site-Directed Mutagenesis protocol (Stratagene, Amsterdam, The Netherlands) and confirmed by sequencing.
Transfection of JEG3 cells
JEG3 cells were grown at 37 C in DMEM-F12 medium containing 9% fetal bovine serum and 100 nm sodium selenite and transfected at 70 -80% confluency using 0.3 l FuGENE 6 transfection reagent (Roche Diagnostics, Almere, The Netherlands) per 100 ng DNA. For T 3 uptake studies and immunoblotting (IB), cells were grown in six-well plates and transfected with 500 ng empty pcDNA3 or pcDNA3 containing wildtype or mutated MCT8 cDNA. Renilla luciferase vector (50 ng; pRL-SV40; Promega, Leiden, The Netherlands) was cotransfected to enable correction for transfection efficiency. For intact-cell T 3 metabolism assays, cells were cultured in 24-well plates and cotransfected with 100 ng pcDNA3 containing wild-type or mutant MCT8 and 100 ng pCI-Neo containing D3 cDNA (14) . For analysis of D3 activity in cell lysates, JEG3 were cotransfected for 48 h with 500 ng wild-type or mutant MCT8 and 500 ng human D3 cDNA in six-well plates. For immunocytochemistry (ICC), cells were cultured on 15-mm coverslips and transfected with 100 ng cDNA.
T 3 uptake and metabolism assays, IB, and ICC
Two days after transfection, cells were rinsed with DMEM-F12 medium plus 0.1% BSA. For the T 3 uptake assay, the cells were incubated for 5 min at 37 C in 1.5 ml DMEM-F12/0.1% BSA containing 1 or 100 nm (2 ϫ 10 5 cpm) [ 125 I]T 3 (Amersham Biosciences, Roosendaal, The Netherlands). Incubation was stopped by removing the medium and washing once with DMEM-F12/0.1% BSA. Cells were lysed with 0.1 m NaOH, and the lysates were counted in a ␥ counter. Renilla luciferase activity was measured in parallel wells according to the protocol of the manufacturer.
For the intact-cell T 3 metabolism assay, MCT8 and D3 (co)transfected cells were incubated for 4 h at 37 C in 0.5 ml DMEM-F12/0.1% BSA containing 1 nm (1 ϫ 10 6 cpm) [ 125 I]T 3 . After incubation, medium was harvested and analyzed by HPLC as described previously (14) . For analysis of D3 activity in cell lysates, cells were harvested in PE buffer [0.1 m phosphate (pH 7.2), 2 mm EDTA] containing 1 mm dithiothreitol and sonicated. Appropriate dilutions of the sonicates were incubated for 1 h at 37 C with 1 nm (2 ϫ 10 5 cpm) [ 125 I]T 3 in 0.1 ml PE buffer containing 10 mm dithiothreitol. Incubations were stopped, and samples were analyzed by HPLC. IB of transfected cell homogenates was performed as described previously (14) . For ICC, cells were fixed and permeabilized with 4% paraformaldehyde and 0.2% Triton X-100 and stained with MCT8-specific polyclonal antibody 1306. The plasma membrane was stained using zona occludens 1 antibody (Invitrogen, Breda, The Netherlands). Alexa fluor 488 and 633 (Invitrogen) were used as detection antibodies; analyses were performed on a Zeiss Axiovert 100 confocal microscope (Zeiss, Sliedrecht, The Netherlands) using Zeiss LSM software.
Results
We report here on nine boys with severe psychomotor retardation, five of which have been presented previously ( Table 1 ). The clinical phenotypes and serum thyroid parameters of the additional four patients are similar to those of patients with MCT8 mutations described by us and others. All of our patients have been identified with severe psychomotor retardation, characterized by axial hypotonia, spastic or flaccid quadriplegia, dystonic movements, and absence of speech. Mean serum T 4 and free T 4 are decreased, TSH is mildly increased, and serum T 3 is markedly elevated. Patients are between 2.5 and 18 yr old and come from various ethnic backgrounds.
All nine patients were found to have different hemizygous mutations in MCT8 (Table 1) . Patient 1 has a 24,527 bp deletion, stretching from 15 kb upstream to 9 kb downstream of exon 1. Patient 2 has a 671C3 T missense mutation in exon 2, resulting in an Ala224Val substitution located in the second putative TMD (9, 15) . Patient 3 has a 1412T3 C mutation in exon 5, resulting in a Leu471Pro substitution located in the ninth TMD (9) . Patient 4 has a 2374 bp deletion, which comprises a large part of exon 3, entire intron 3 and exon 4, and part of intron 4. Patient 5 has a nonsense 733C3 T mutation in exon 2, resulting in premature translation termination (Arg245stop) (9) . Patient 6 has a missense 812G3 A mutation in exon 3, resulting in an Arg271His substitution located in the second extracellular loop. Patient 7 has a 14-bp deletion (nucleotides 631-644), resulting in a frame shift and truncation of the protein at amino acid residue 235. Patient 8 has a G3 C mutation in the acceptor splice site of exon 3, i.e. ACCT instead of AGCT. RT-PCR analysis of mRNA isolated from fibroblasts of his affected brother indicated the loss of 282 nucleotides from exon 3 and, thus, of 94 amino acids, including TMDs 4 -6. Patient 9 has a 3-bp (TCT) deletion in exon 2, leading to deletion of Phe230. Figure 1A shows the uptake of T 3 by JEG3 cells transfected with wild-type or mutant MCT8 cDNA after 5 min of incubation at 37 C. Significant T 3 uptake was observed in empty pcDNA3-transfected cells. JEG3 cells do not show endogenous expression of MCT8 (14) . Therefore, this background uptake is likely facilitated by other, as yet unidentified, transporter(s). Transfection with wild-type MCT8 increased T 3 uptake 2.8-fold. Transfection of cells with MCT8 mutants Ala224Val, Leu471Pro, Arg245stop, splice site mutant ex3 Ϫ1G3 C, and delPhe230 did not increase T 3 uptake over control cells. However, transfection with the MCT8 Arg271His mutant induced a modest but significant 1.4-fold increase in T 3 uptake (P Ͻ 0.05). Uptake experiments using 100 nm T 3 produced similar results (data not shown).
JEG3 cells transfected with control plasmid or MCT8 cDNA alone did not show significant metabolism of T 3 , indicating very low deiodination capacity of these cells (data not shown). Figure 1B shows that transfection with D3 cDNA resulted in 11% metabolism of T 3 after 4 h. Cotransfection of cells with wild-type MCT8 and D3 greatly increased T 3 metabolism to approximately 60%. Cotransfection of cells with the MCT8 Ala224Val, Leu471Pro, Arg245stop, or delPhe230 mutants and D3 did not increase T 3 metabolism compared with D3 transfection alone. However, cotransfection with the MCT8 Arg271His mutant and D3 showed 20% metabolism, again indicating that some T 3 transport is preserved in this mutant.
D3 activity in lysates of JEG3 cells cotransfected with the different MCT8 mutants amounted to 85-123% of that in cells cotransfected with wild-type MCT8 (Fig. 1D) , indicating that the impaired T 3 metabolism in intact cells cotransfected with mutant vs. wild-type MCT8 is indeed attributable to inhibited T 3 uptake rather than decreased D3 expression. IB (Fig.  1C) showed marked expression of wild-type MCT8 and of mutants Ala224Val and Arg271His, little expression of Leu471Pro and delPhe230, and no expression of splice site mutant ex3 Ϫ1G3 C and Arg245stop. Control cells transfected with pcDNA3 also showed no expression of MCT8. ICC demonstrated marked plasma membrane expression of wild-type MCT8 and mutant Arg271His, whereas Ala224Val was mainly localized in the cytoplasm. Leu471Pro, ex3 Ϫ1G3 C, and delPhe230 showed very little expression of protein (data not shown).
Discussion
We present nine unrelated young males with severe Xlinked psychomotor retardation and elevated serum T 3 levels Our findings associate the psychomotor retardation observed in MCT8 patients with loss of T 3 transport capacity. This illustrates that MCT8 is crucial for normal thyroid hormone-dependent development of the central nervous system in humans. Thyroid hormone plays a crucial role in processes such as cell migration, dendritic outgrowth, the formation of synapses, and myelination (16) . Neurons are the major target cells for thyroid hormone, expressing T 3 receptors (17) and D3 and MCT8 (8) . Loss-of-function mutations in MCT8 lead to reduced or absent supply of T 3 to neurons, resulting in impaired neurological development as well as a reduced clearance of T 3 by neuronal D3. The role of MCT8 in neuronal T 3 uptake was recently studied in MCT8 knockout mice by Dumitrescu et al. (18) and Trajkovic et al. (19) . They show reduced T 3 concentrations, increased type II deiodinase activity, and reduced D3 activity in brain, reflecting local hypothyroidism, despite elevated serum T 3 . Trajkovic et al. (19) also show reduced expression of the thyroid hormone-regulated genes TRH and RC3 in neurons, supporting hypothyroid state at the cellular level. It must be noted, however, that, although MCT8-deficient mice show reduced T 3 concentrations in the brain, they do not show an apparent neurological phenotype. This suggests differences in the role of MCT8 in the development of the central nervous system between the two species.
In conclusion, the experiments presented here support the hypothesis of reduced supply of T 3 to neurons in patients with mutations in MCT8. The severe psychomotor retardation observed in these patients clearly illustrates the important role of thyroid hormone in human neuronal development.
